Biomerica, Inc (BMRA): Bathi resik saben saham (EPS TTM)

Biomerica, Inc. (BMRA) market positions are limited to narrow GI diagnostics niches, despite patent protection. The rolling net income per share snapshot demonstrates the current adaptability of the business, where -1.65 reflects the latest metric value. Growth is driven by the expansion of non-invasive tests into pharmacy chains, while resilience is bolstered by the implementation of ESG environmental standards and packaging recycling.
Rincian metrik lan analitis perusahaan Biomerica Inc (BMRA)

For Biomerica, Inc. (BMRA), earnings per share reflects the monetization efficiency of InFoods tests and the reach of pharmacy chains. This indicator is calculated as the ratio of total annual income to the total number of outstanding securities. By analyzing a slice of rolling earnings per share, an investor separates real returns from price volatility. This metric allows for an assessment of capital dilution risk, serving as a key marker of business sustainability.